HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EC’s hair-dye mission continues

This article was originally published in The Rose Sheet

Executive Summary

European Commission is requesting opinion from its Scientific Committee on Consumer Products regarding a December 2007 position paper from the European Cosmetics Association (Colipa) related to reaction products formed in the use of permanent hair dyes. In a previous opinion, SCCP considered a Colipa report suggesting that oxidative hair dye reaction products pose no or negligible risks to human health and determined the study insufficient because it covered a limited number of ingredient combinations (11) and used a cream base that contained "only basic ingredients" and therefore was not representative of marketplace (1"The Rose Sheet" Feb. 20, 2006, p. 10). In light of new Colipa submission, EC asks SCCP whether further testing with regard to potential mutagenicity and carcinogenicity of intermediates and reaction products is needed. Evaluation of reaction products is third step in overall strategy adopted by EC to regulate hair-dye substances following impact of 2001 study linking permanent hair dye use to bladder cancer. Separately EC requests that SCCP weigh in on data submitted for new hair dye substance 2-Amino-5-ethylphenol HCl

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015658

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel